Clinical Trials for Bone Marrow/

7 Open Trials

Trial Type &
Disease
Protocol No. &
Open Date
Summary
Therapeutic
Leukemia
ECOGHEME2906
01/20/2012
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age greater than or equal to 60 Years)
Therapeutic
Multiple Myeloma
VICCBMT1049
11/17/2011
A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma
Therapeutic
Hematologic
VICCBMT1158
10/20/2011
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and other Indications
Therapeutic
Leukemia
ECOGBMTS0805
09/14/2011
Phase II Study of Combination of Hyper-CVAD and Dasatinib (NSC-732517) With or Without Allogeneic Stem Cell Transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
Therapeutic
Benign Hematologic
VICCNCPED1099
06/04/2010
Nonmyeloablative Hematopoietic Cell Transplantation for Patients with Fanconi Anemia Using Alternative Marrow Donors: A Phase I/II Dose-Finding Study
Therapeutic
Benign Hematologic
VICCNCPED10101
12/28/2006
Hematopoietic Cell Transplantation for Treatment of Patients with Primary Immunodeficiencies and Other Nonmalignant Inherited Disorders Using Low-Dose TBI and Fludarabine with or without Campath
Epidemiology, Observation, Outcomes
Other Hematopoietic
VICCNCPED1166
08/23/2011
Allogeneic hematopoietic cell transplantation for patients with nonmalignant inherited disorders using a Treosulfan based preparative regimen.

Back to Find By Treatment

You do not have JavaScript enabled. This site works better with JavaScript turned on.